Soung-Hoon Lee

Soung-Hoon Lee


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2025 in Cells
Verified
Journal Article
Open access
PDF file
SLSoung-Hoon Lee
Soung-Hoon Lee
Wound-induced hair-follicle neogenesis (WIHN) is the phenomenon of regenerating new hair follicles from wounds in mammals. The WIHN involves both developmental and adult wound-healing processes. Moreover, the WIHN is regulated by a variety of factors, particularly multiple molecular signaling pathways produced in several types of cells. Here, the role of multiple signaling in different types of cells in WIHN is comprehensively described. Furthermore, the lack of dermal γδ T cells in the human scalp has hindered the clinical application of WIHN, but the development of drugs such as Wnt signaling activators is increasing the effectiveness of WIHN in humans. Overall, understanding the underlying mechanisms that regulate WIHN may help treat skin diseases, including alopecia.

27 May 2024 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
CLChae Ho Lim
Chae Ho Lim
AKAnnette Kaminaka
Annette Kaminaka
SLSoung-Hoon Lee
Soung-Hoon Lee
SMSimone Moore
Simone Moore
BCBruce Cronstein
Bruce Cronstein
MIMayumi Ito
Mayumi Ito

2 July 2024 in Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Closed access
PDF file
JPJung Min Park
Jung Min Park
SCSeock Hwan Choi
Seock Hwan Choi
ELEun-Shil Lee
Eun-Shil Lee
SGSang-Il Gum
Sang-Il Gum
SHSungkuk Hong
Sungkuk Hong
JOJi Won Oh
Ji Won Oh

22 May 2026 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
JPJung Min Park
Jung Min Park
SLSoung-Hoon Lee
Soung-Hoon Lee
ACAreum Cho
Areum Cho
NMNanda Maya Mali
Nanda Maya Mali
RPRalf Paus
Ralf Paus
JOJi Won Oh
Ji Won Oh

1 September 2025 in Experimental & Molecular Medicine
Verified
Journal Article
Open access
PDF file
SLSoung-Hoon Lee
Soung-Hoon Lee
MKMin-Jeong Kang
Min-Jeong Kang
MRMi Ryung Roh
Mi Ryung Roh
KCKang-yell Choi
Kang-yell Choi
The Wnt/β-catenin pathway is an attractive target for drug development in various diseases; however, efforts to target it have been limited due to its concerning role in cancer. We previously developed KY19382 and KY19334, small molecules that inhibit the cytosolic function of CXXC-type zinc finger protein 5 (CXXC5), as safe therapeutic agents to restore the suppressed Wnt/β-catenin signaling in several intractable diseases, but the effects of these small molecules on cancer have not been determined. Here, we found that KY19382 and KY19334 inhibited the manifestation of malignant phenotype by inhibiting the Wnt/β-catenin signaling of human cutaneous squamous cell carcinoma (cSCC) cells, which was associated with suppression of cyclin-dependent kinase 1 (CDK1) expression. The induced expression of CDK1 and subsequent Wnt/β-catenin pathway activation were observed in human cSCC patient samples compared with normal samples, and the roles of CDK1 in cellular transformation and Wnt/β-catenin pathway activation in human cSCC cells were validated by CDK1 knockdown. Moreover, the two small molecules attenuated two-stage mouse skin carcinogenesis. Overall, KY19382 and KY19334 could be used as agents to treat cSCC and other types of cancer caused by CDK1 overexpression, as well as diseases caused by cytoplasmic accumulation of CXXC5.